- Home
- LESL vs CRVO Comparison
LESL vs CRVO Comparison
Compare LESL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- CRVO
- Stock Information
- Founded
- LESL 1963
- CRVO 2001
- Country
- LESL United States
- CRVO United States
- Employees
- LESL N/A
- CRVO N/A
- Industry
- LESL Diversified Commercial Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- CRVO Health Care
- Exchange
- LESL Nasdaq
- CRVO Nasdaq
- Market Cap
- LESL 66.9M
- CRVO 67.4M
- IPO Year
- LESL 2020
- CRVO N/A
- Fundamental
- Price
- LESL $3.96
- CRVO $6.74
- Analyst Decision
- LESL Hold
- CRVO Strong Buy
- Analyst Count
- LESL 9
- CRVO 6
- Target Price
- LESL $33.25
- CRVO $19.17
- AVG Volume (30 Days)
- LESL 198.8K
- CRVO 111.6K
- Earning Date
- LESL 11-24-2025
- CRVO 11-12-2025
- Dividend Yield
- LESL N/A
- CRVO N/A
- EPS Growth
- LESL N/A
- CRVO N/A
- EPS
- LESL N/A
- CRVO N/A
- Revenue
- LESL $1,250,568,000.00
- CRVO $7,776,968.00
- Revenue This Year
- LESL N/A
- CRVO N/A
- Revenue Next Year
- LESL N/A
- CRVO N/A
- P/E Ratio
- LESL N/A
- CRVO N/A
- Revenue Growth
- LESL N/A
- CRVO N/A
- 52 Week Low
- LESL $3.50
- CRVO $1.80
- 52 Week High
- LESL $72.60
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- LESL 55.65
- CRVO 33.98
- Support Level
- LESL $3.50
- CRVO $6.76
- Resistance Level
- LESL $4.52
- CRVO $7.30
- Average True Range (ATR)
- LESL 0.38
- CRVO 0.45
- MACD
- LESL -0.17
- CRVO -0.08
- Stochastic Oscillator
- LESL 33.33
- CRVO 1.24
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.